Suppr超能文献

药物的肾小管处理

Renal tubular handling of drugs.

作者信息

Cafruny E J

出版信息

Am J Med. 1977 Apr;62(4):490-6. doi: 10.1016/0002-9343(77)90403-x.

Abstract

The renal excretion of drugs is a vectorial quantity, the resultant of physiologic mechanisms that have directional orientation and magnitude. Magnitude is limited by a variety of extrarenal factors including plasma protein binding and the volume of the total body water. The contributions of the glomeruli and tubules to excretion varies with age. This fact has clinical relevance, especially in newborn children and older patients. Although protein binding reduces the amount of a drug that can be filtered, it usually does not alter the rate of proximal tubular secretion of charged organic molecules. Reabsorption of the filtered fluid from tubular lumens creates concentration gradients favoring the reabsorption of drugs, but the movement of drug molecules out of luminal fluid is hindered by the formation of polar drug metabolites in the liver. Although there are only a few examples in the literature, it is probable that many drugs are reabsorbed by a carrier-mediated process located in the proximal tubules. A major difference exists between the renal handling of chlormerodrin, a neutral mercurial, and of mersalyl, an acidic mercurial. Chlormerodrin is reabsorbed (as a complex with cysteine) by a carrier-mediated process; mersalyl is secreted by one of the organic anion transport systems.

摘要

药物的肾排泄是一个矢量,是具有方向和大小的生理机制的结果。其大小受到多种肾外因素的限制,包括血浆蛋白结合和总体液量。肾小球和肾小管对排泄的贡献随年龄而异。这一事实具有临床相关性,尤其是在新生儿和老年患者中。虽然蛋白结合会减少可滤过的药物量,但通常不会改变带电荷有机分子在近端肾小管的分泌速率。从肾小管腔中重吸收滤过液会形成有利于药物重吸收的浓度梯度,但肝脏中极性药物代谢产物的形成会阻碍药物分子从管腔液中移出。虽然文献中只有少数例子,但很可能许多药物是通过位于近端小管的载体介导过程进行重吸收的。中性汞剂氯汞丙脲和酸性汞剂汞撒利在肾脏处理上存在重大差异。氯汞丙脲(与半胱氨酸形成复合物)通过载体介导过程被重吸收;汞撒利则通过有机阴离子转运系统之一进行分泌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验